Advertisement

Topics

BioTime to Participate in Upcoming Conferences

07:00 EST 13 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
BioTime, Inc. (NYSE American: BTX), a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases, today announced that its management will participate in the fol...

Other Sources for this Article

Investor Contact:
BioTime
David Nakasone, 510-871-4188
Dnakasone@biotime.com
Media Contact:
JQA Partners, Inc.
Jules Abraham, 917-885-7378
jabraham@jqapartners.com

NEXT ARTICLE

More From BioPortfolio on "BioTime to Participate in Upcoming Conferences"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...